ESC Premium Access

Continuous vs. interrupted anticoagulation for atrial fibrillation ablation patients - what do the data tell us?

Congress Presentation

About the speaker

Professor Luigi Di Biase

Albert Einstein Medical Center at Montefiore Health System, The Bronx (United States of America)
21 presentations
0 follower

3 more presentations in this session

Silent brain lesions and clinically relevant bleeds - the next frontiers for making atrial fibrillation ablation safer.

Speaker: Professor L. Mont (Barcelona, ES)

Thumbnail

Who should be considered for left atrial appendage occlusion in the era of direct anticoagulants?

Speaker: Professor M. Glikson (Jerusalem, IL)

Thumbnail

The key question: can anticoagulation be abandoned after catheter ablation of atrial fibrillation?

Speaker: Doctor A. Verma (Montreal, CA)

Thumbnail

Access the full session

Atrial fibrillation ablation: stroke and bleeding

Speakers: Professor L. Di Biase, Professor L. Mont, Professor M. Glikson, Doctor A. Verma
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk